Sodium Zirconium Cyclosilicate Generics

Form: Powder for oral suspension

Strength: 5g, 7g,10g sachets

Reference Brands: Lokelma® (EU & US)

Category: Nephrology

Sodium Zirconium Cyclosilicate (SZC), marketed as Lokelma®, is a novel, highly selective potassium binder used to treat hyperkalemia in patients with chronic kidney disease, heart failure, or those on RAAS inhibitors. Approved by the FDA and EMA, it offers rapid onset and sustained potassium control with excellent tolerability. Available as a powder for oral suspension in 5 g and 10 g strengths, SZC is in high demand across EU and US pharmaceutical B2B markets. Ideal for licensing, distribution, and contract manufacturing partnerships, SZC represents a valuable addition to renal and cardiovascular therapeutic portfolios in regulated international markets.